Boenning & Scattergood Starts Nektar Therapeutics (NKTR) at Outperform
Tweet
Share
E-mailGet Alerts NKTR Hot Sheet
Price: $74.02 -0.68%
Rating Summary:
20 Buy, 8 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
20 Buy, 8 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Boenning & Scattergood initiates coverage on Nektar Therapeutics (NASDAQ: NKTR) with an Outperform. PT $15.
For more ratings news on Nektar Therapeutics click here and for the rating history of Nektar Therapeutics click here.
Shares of Nektar Therapeutics closed at $9.95 yesterday.
For more ratings news on Nektar Therapeutics click here and for the rating history of Nektar Therapeutics click here.
Shares of Nektar Therapeutics closed at $9.95 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Reinstates Nektar Therapeutics (NKTR) at Neutral
- Keefe, Bruyette & Woods Resumes Toronto-Dominion Bank (TD:CN) (TD) at Market Perform
- BofA Securities Starts Mobility Global (MBGL) at Neutral
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Boenning & ScattergoodSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
